Nuclear Regulatory Commission November 22, 2022 – Federal Register Recent Federal Regulation Documents
Results 1 - 3 of 3
Perma-Fix Northwest Richland, Inc.
On October 17, 2022, the U.S. Nuclear Regulatory Commission (NRC) received an application to amend an export license (XW027/01), from Perma-Fix Northwest Richland, Inc. (PFNW), authorizing the export of low-level radioactive waste to Eckert and Ziegler Nuclitech GmbH located in Germany. The request seeks the NRC's approval to amend an existing license authorizing the export of radioactive waste to Germany. The NRC is providing notice of the opportunity to comment, request a hearing, and petition to intervene on PFNW's application.
Fitness for Duty Drug Testing Requirements
The U.S. Nuclear Regulatory Commission (NRC) is amending its regulations regarding fitness for duty (FFD) programs for certain NRC licensees and other entities to align the NRC's drug testing requirements more closely with the updates made to the U.S. Department of Health and Human Services' ``Mandatory Guidelines for Federal Workplace Drug Testing Programs'' in 2008 and as revised in 2017. This final rule also incorporates lessons learned from implementing the NRC's current FFD regulations. These changes enhance the ability of NRC licensees and other entities to identify individuals using illegal drugs, misusing legal drugs, or attempting to subvert the drug testing process. This final rule provides additional protections to individuals subject to drug testing and improves the clarity, organization, and flexibility of the NRC's FFD regulations. This final rule provides a new flexibility for the collection and drug testing of an oral fluid specimen as an alternative to the collection and testing of a urine specimen under direct observation conditions. The NRC also is issuing final implementation guidance for this final rule.
Advisory Committee on the Medical Uses of Isotopes: Call for Nominations
The U.S. Nuclear Regulatory Commission (NRC) is soliciting nominations for the position of Radiation Oncologist Physician (Brachytherapy) on the Advisory Committee on the Medical Uses of Isotopes (ACMUI). Nominees should be currently practicing radiation oncologists.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.